HFIP extraction followed by 2D CTAB/SDS-PAGE separation: A new methodology for protein identification from tissue sections after MALDI mass spectrometry profiling for personalized medicine research

OMICS A Journal of Integrative Biology

Volumn 18, Issue 6, 2014, Pages 374-384

  Longuespée, Rémi ^a,b   Tastet, Christophe ^a   Desmons, Annie ^a   Kerdraon, Olivier ^a,c   Day, Robert ^b   Fournier, Isabelle ^a   Salzet, Michel ^a  

^a UNIV LILLE   (France)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAFLUORO 2 PROPANOL; PROTEIN; TRYPSIN; PROTEOME;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION MASS SPECTROMETRY; PERSONALIZED MEDICINE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; TISSUE SECTION; TWO DIMENSIONAL CETYL TRIMETHYLAMMONIUM BROMIDE SODIUM DODECYL SULFATE POLYACRYLAMIDE GEL ELECTROPHORESIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; CHEMISTRY; FEMALE; OVARY TUMOR; PROCEDURES; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

FEMALE; HUMANS; INDIVIDUALIZED MEDICINE; OVARIAN NEOPLASMS; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84902264337     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2013.0176     Document Type: Article

References (40)

1. Balluff B, Rauser S, Meding S, et al. (2011). MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. Am J Pathol 179, 2720-2729.
2. Bekku S, Mochizuki H, Yamamoto T, Ueno H, Takayama E, and Tadakuma T. (2000). Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer. Hepatogastroenterology 47, 998-1001.
3. Bonnel D, Longuespee R, Franck J, et al. (2011). Multivariate analyses for biomarkers hunting and validation through on-tissue bottom-up or in-source decay in MALDI-MSI: Application to prostate cancer. Anal Bioanal Chem 401, 149-165.
4. Braun RJ, Kinkl N, Beer M, and Ueffing M. (2007). Two-dimensional electrophoresis of membrane proteins. Anal Bioanal Chem 389, 1033-1045.
5. Calligaris D, Longuespee R, Debois D, et al., (2013). Selected protein monitoring in histological sections by targeted MALDI-FTICR in-source decay imaging. Anal Chem 85, 2117-2126.
6. Colinge J, Chiappe D, Lagache S, Moniatte M, and Bougueleret L. (2005). Differential proteomics via probabilistic peptide identification scores. Anal Chem 77, 596-606.
7. Deininger SO, Ebert MP, Futterer A, Gerhard M, and Rocken C. (2008). MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. J Proteome Res 7, 5230-5236.
8. Di Michele M, Marcone S, Cicchillitti L, et al. (2010). Glyco-proteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: Towards the identification of putative biomarkers. J Proteomics 73, 879-898.
9. Dong HP, Holth A, Kleinberg L, et al. (2009). Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: Clinical relevance and comparison with other apoptosis parameters. Am J Clin Pathol 132, 756-762.
10. El Ayed M, Bonnel D, Longuespee R, et al. (2010). MALDI imaging mass spectrometry in ovarian cancer for tracking, identifying, and validating biomarkers. Med Sci Monit 16, BR233-245.
11. Elsner M, Rauser S, Maier S, et al. (2012). MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarci-noma. J Proteomics 75, 4693-4704.
12. Franck J, Longuespee R, Wisztorski M, et al. (2010). MALDI mass spectrometry imaging of proteins exceeding 30, 000 daltons. Med Sci Monit 16, BR293-299.
13. Gagnon H, Franck J, Wisztorski M, Day R, Fournier I, and Salzet M. (2012). Targeted mass spectrometry imaging: Specific targeting mass spectrometry imaging technologies from history to perspective. Prog Histochem Cytochem 47, 133-174.
14. Iwanicki MP, Davidowitz RA, Ng MR, et al. (2012). Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discov 1, 144-157.
15. Lemaire R, Desmons A, Tabet JC, Day R, Salzet M, and Fournier I. (2007). Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections. J Proteome Res 6, 1295-1305.
16. Lemaire R, Wisztorski M, Desmons A, et al. (2006). MALDI-MS direct tissue analysis of proteins: Improving signal sensitivity using organic treatments. Anal Chem 78, 7145-7153.
17. Lokman NA, Ween MP, Oehler MK, and Ricciardelli C. (2011). The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron 4, 199-208.
18. Longuespee R, Boyon C, Castellier C, et al. (2012a). The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: Evidence from mass spectrometry profiling. Histochem Cell Biol 138, 141-154.
19. Longuespee R, Boyon C, Desmons A, et al. (2013a). Spectro- immunohistochemistry: A novel form of MALDI mass spectrometry imaging coupled to immunohistochemistry for tracking antibodies. Omics 2, 132-141.
20. Longuespee R, Boyon C, Desmons A, et al. (2012b). Ovarian cancer molecular pathology. Cancer Metastasis Rev 31, 713-732.
21. Longuespee R, Gagnon H, Boyon C, et al. (2013b). Proteomic analyses of serous and endometrioid epithelial ovarian cancers-Cases studies-Molecular insights of a possible histological etiology of serous ovarian cancer. Proteomics Clin Appl 7, 337-354.
22. Lyubimova T, Caglio S, Gelfi C, Righetti PG, and Rabilloud T. (1993). Photopolymerization of polyacrylamide gels with methylene blue. Electrophoresis 14, 40-50.
23. Maier SK, Hahne H, Moghaddas Gholami A, et al. (2013). Comprehensive identification of proteins from MALDI imaging. Mol Cell Proteomics 12, 2901-2910.
24. Meding S, Balluff B, Elsner M, et al. (2012). Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer. J Pathol doi: 10.1002/path.4021 [Epub ahead of print].
25. Nanduri B, Lawrence ML, Vanguri S, Pechan T, and Burgess SC. (2005). Proteomic analysis using an unfinished bacterial genome: The effects of subminimum inhibitory concentrations of antibiotics on Mannheimia haemolytica virulence factor expression. Proteomics 5, 4852-4863.
26. Pocsfalvi G, Votta G, De Vincenzo A, et al. (2011). Analysis of secretome changes uncovers an autocrine/paracrine component in the modulation of cell proliferation and motility by c-Myc. J Proteome Res 10, 5326-5337.
27. Polati R, Zapparoli G, Giudici P, and Bossi A. (2009). A CTAB based method for the preparation of total protein extract of wine spoilage microrganisms for proteomic analysis. J Chromatog B, Anal Technol Biomed Life Sci 877, 887-891.
28. Prokocimer M, Davidovich M, Nissim-Rafinia M, et al. (2009). Nuclear lamins: Key regulators of nuclear structure and activities. J Cell Mol Med 13, 1059-1085.
29. Quanico J, Franck J, Dauly C, et al. (2013). Development of liquid microjunction extraction strategy for improving protein identification from tissue sections. J Proteomics 79, 200-218.
30. Rao LV, Tait JF, and Hoang AD. (1992). Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity. Thromb Res 67, 517-531.
31. Stauber J, Ayed ME, Wisztorski M, Salzet M, and Fournier I. (2010). Specific MALDI-MSI: Tag-Mass. Methods Mol Biol 656, 339-361.
32. Stauber J, Lemaire R, Franck J, et al. (2008). MALDI imaging of formalin-fixed paraffin-embedded tissues: Application to model animals of Parkinson disease for biomarker hunting. J Proteome Res 7, 969-978.
33. Sternberger LA, Hardy PH, Jr., Cuculis JJ, and Meyer HG. (1970). The unlabeled antibody enzyme method of immuno-histochemistry: Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase- antihorseradish per-oxidase) and its use in identification of spirochetes. J Histochem Cytochem 18, 315-333.
34. Stevens SM, Jr., Chung AY, Chow MC, et al. (2005). Enhancement of phosphoprotein analysis using a fluorescent affinity tag and mass spectrometry. Rapid Commun Mass Spectrom 19, 2157-2162.
35. Sugimura M, Donato R, Kakkar VV, and Scully MF. (1994). Annexin V as a probe of the contribution of anionic phos-pholipids to the procoagulant activity of tumour cell surfaces. Blood Coagul Fibrinolysis 5, 365-373.
36. Van Remoortere A, Van Zeijl RJ, Van Den Oever N, Fet al. (2010). MALDI imaging and profiling MS of higher mass proteins from tissue. J Am Soc Mass Spectrom 21, 1922-1929.
37. Wisztorski M, Fatou B, Franck J, et al. (2013). Microproteomics by liquid extraction surface analysis: Application to FFPE tissue to study the fimbria region of tubo-ovarian cancer. Proteomics Clin Appl 7, 234-240.
38. Xue LY, Teng LH, Zou SM, et al. (2007). [Expression of an-nexin I in different histological types of carcinomas]. Zhon-ghua Zhong Liu Za Zhi 29, 444-448.
39. Yamaguchi Y, Miyagi Y, and Baba H. (2008a). Two-dimensional electrophoresis with cationic detergents, a powerful tool for the proteomic analysis of myelin proteins. Part 1: Technical aspects of electrophoresis. J Neurosci Res 86, 755-765.
40. Yamaguchi Y, Miyagi Y, and Baba H. (2008b). Two-dimensional electrophoresis with cationic detergents, a powerful tool for the proteomic analysis of myelin proteins. Part 2: Analytical aspects. J Neurosci Res 86, 766-775.